Takayo Ota
10PUBLICATIONS
16CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (10)
Sort by Publication Date:
|Mar 24, 2025
PD-1/PD-L1 checkpoint inhibitor-induced encephalitis in patients with lung adenocarcinoma: a report of three cases.Takayo Ota, Masaaki Terashima, Yukihiro Hamada
|Mar 23, 2025
Serum VEGF-A as a biomarker for the addition of bevacizumab to chemo-immunotherapy in metastatic NSCLC.Kentaro Tanaka, Jun Sugisaka, Yoshimasa Shiraishi
|Sep 28, 2024
Feasibility Study of Nivolumab in Combination with Carboplatin Plus Paclitaxel and Concurrent Thoracic Radiation in Patients with Untreated Unresectable Locally Advanced Non-Small Cell Lung Cancer.Yuta Yamanaka, Takayo Ota, Yutaka Masuoka
|May 07, 2023
Long-term survival with nivolumab followed by irinotecan after total gastrectomy in alpha-fetoprotein-producing gastric cancer: a case report and review of the literature.Takayo Ota, Katsuya Sakashita, Ryugo Sawada
|Feb 22, 2023
Comprehensive Kinase Activity Profiling Revealed the Kinase Activity Patterns Associated with the Effects of EGFR Tyrosine Kinase Inhibitor Therapy in Advanced Non-Small-Cell Lung Cancer Patients with Sensitizing EGFR Mutations.Rei Noguchi, Akihiro Yoshimura, Junji Uchino
|Sep 06, 2021
Rapid and dramatic responses to dabrafenib and trametinib in BRAF V600E-mutated lung adenocarcinoma.Takayo Ota, Aya Okabayashi, Masahiro Fukuoka
Pageof 2
Frequent Collaborators
2 joint publications
Takayuki Takeda
1 joint publications
Kenji Tezuka
1 joint publications
Rei Noguchi
1 joint publications
Akihiro Yoshimura
1 joint publications
Junji Uchino
1 joint publications
Hiroshi Gyotoku
1 joint publications
Koichi Takayama
1 joint publications
Tadashi Kondo
1 joint publications
Yuta Yamanaka
1 joint publications
Yutaka Masuoka
